Lenacapavir Plus Cabotegravir as Combination Treatment: Real-world Use Cases From the National Clinician Consultation Center
These data support further investigations into LEN+ CAB+/-RPV use among PWH with oral ART challenges and/or drug resistance.
Authors
- Monica Gandhi (ORCID: https://orcid.org/0000-0002-7025-1994)
- April Nakayoshi
- Chris Bositis
- Parya Saberi (ORCID: https://orcid.org/0000-0002-3793-5112)
- Cara McAnaney (ORCID: https://orcid.org/0000-0001-7171-6223)
- Carolyn Chu (ORCID: https://orcid.org/0000-0003-0780-1081)
Institutions
- University of California, San Francisco (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1093/ofid/ofaf651
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00